BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 16700857)

  • 21. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
    Umene-Nakano W; Yoshimura R; Yoshii C; Hoshuyama T; Hayashi K; Hori H; Katsuki A; Ikenouchi-Sugita A; Nakamura J
    Hum Psychopharmacol; 2010 Apr; 25(3):276-9. PubMed ID: 20373480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
    Hays JT; Ebbert JO
    Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A second varenicline trial.
    O'Brien CP
    Curr Psychiatry Rep; 2007 Oct; 9(5):346-7. PubMed ID: 17915071
    [No Abstract]   [Full Text] [Related]  

  • 25. [On oral medications, especially varenicline].
    Kurioka N
    Nihon Rinsho; 2013 Mar; 71(3):487-92. PubMed ID: 23631241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Varenicline: for smoking cessation.
    Rao J; Shankar PK
    Kathmandu Univ Med J (KUMJ); 2009; 7(26):162-4. PubMed ID: 20071853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced affective symptoms during tobacco dependence treatment with varenicline.
    Grosshans M; Mutschler J; Hermann D; Mann K; Diehl A
    Addiction; 2009 May; 104(5):859-61. PubMed ID: 19413797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varenicline in smoking cessation.
    Tonstad S; Rollema H
    Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug treatment of tobacco dependence].
    Friederich HM; Batra A
    Dtsch Med Wochenschr; 2009 Nov; 134(47):2402-5. PubMed ID: 19911331
    [No Abstract]   [Full Text] [Related]  

  • 31. The relevance and treatment of cue-induced cravings in tobacco dependence.
    Ferguson SG; Shiffman S
    J Subst Abuse Treat; 2009 Apr; 36(3):235-43. PubMed ID: 18715743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM
    Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
    Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
    Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current approaches to pharmacotherapy for smoking cessation.
    Hudmon KS; Corelli RL; Prokhorov AV
    Ther Adv Respir Dis; 2010 Feb; 4(1):35-47. PubMed ID: 20056740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.
    Maritz GS
    Ther Adv Respir Dis; 2009 Aug; 3(4):193-210. PubMed ID: 19706643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Varenicline--a new chance for smokers?].
    Goniewicz ML; Koszowski B; CzogaƂa J; Sobczak A
    Przegl Lek; 2007; 64(10):899-902. PubMed ID: 18409337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.